Studies pooled | Treatment | N | # of failures | Person-years | Incidence densitya | PE | 95 % CI lower limit | 95 % CI upper limit |
---|---|---|---|---|---|---|---|---|
030 and 045 | Placebo | 187 | 116 | 22.91 | 506.3 | |||
Tafenoquine 200-mg weekly | 190 | 14 | 42.23 | 33.2 | 93.5 | 88.6 | 96.2 | |
Mefloquine 250-mg weekly | 142 | 8 | 28.67 | 27.9 | 94.5 | 88.7 | 97.3 | |
030, 043 and 045 | Placebo | 247 | 170 | 30.59 | 555.7 | |||
Tafenoquine 200-mg weekly | 245 | 21 | 54.44 | 38.6 | 93.1 | 89.1 | 95.6 |